Innovative Hydrogel Technologies Are Improving Moisture Retention Controlled Drug Release and Tissue Regeneration.
Chemical & Material
Innovative Hydrogel Technologies Are Improving Moisture Retention Controlled Drug Release and Tissue Regeneration.
Biomedical research is expanding hydrogel applications beyond conventional wound dressings into three-dimensional cell culture, organoid development, tissue engineering, and regenerative medicine. One important technology is the extracellular matrix mimicking hydrogel, designed to recreate aspects of the natural environment surrounding cells. By adjusting stiffness, porosity, biochemical signals, and degradation behaviour, researchers can investigate how cells grow, migrate, communicate, and respond to medicines. Another development is animal component free hydrogel matrices, which can reduce dependence on animal-derived culture ingredients and improve consistency in selected laboratory applications. Hydrogels are also being explored as scaffolds for stem cells and regenerative therapies because they can provide a hydrated structure that supports cell attachment or encapsulation. In drug discovery, these systems help researchers study cell behaviour in environments that may more closely resemble living tissue than conventional two-dimensional cultures. In 2024, researchers also demonstrated a bioprinted hydrogel wound dressing containing extracellular vesicles that could be manufactured at the point of need, including in resource limited environments. This illustrates how hydrogel research is combining biomaterials with cell derived biological components and additive manufacturing.
According to the research report "Global Hydrogel Market Outlook, 2031," published by Bonafide Research, the Global Hydrogel Market was valued at more than USD 21.75 Billion in 2025, and expected to reach a market size of more than USD 32.34 Billion by 2031 with the CAGR of 7.01% from 2026-2031. Smart hydrogels are engineered to respond to changes in temperature, pH, light, glucose concentration, enzymes, or other environmental signals. Unlike conventional gels, which mainly provide moisture or physical support, these materials can change their structure, swelling behaviour, or release characteristics when a specific trigger occurs. Temperature sensitive formulations can transition from a liquid to a gel near body temperature, while glucose responsive systems are being studied for more controlled insulin delivery. Polymer science is enabling hydrogels to become more durable, functional, and adaptable to specialised medical applications. Researchers are developing double-network structures, reversible cross links, conductive polymers, and hybrid systems that combine natural and synthetic ingredients. Reversible cross links can allow certain hydrogels to recover after deformation, while double-network designs can improve resistance to mechanical damage. Conductive hydrogels incorporate electrically active components, allowing researchers to investigate applications such as electrical stimulation, wearable bioelectronics, and wound monitoring. For example, a 2024 research study described a flexible photovoltaic powered hydrogel dressing that combined a light-powered electrical system, flexible electrodes and a conductive hydrogel interface to investigate electrical stimulation for infected diabetic wounds.
Synthetic hydrogels hold a strong position globally because manufacturers can engineer their properties to suit different products and performance requirements rather than depending entirely on the characteristics of naturally sourced materials. Polymers such as polyvinyl alcohol (PVA), polyethylene glycol (PEG), and polyacrylate-based materials can be formulated with different crosslinking structures to control water absorption, elasticity, porosity, degradation, and the release of incorporated substances. This adaptability is especially important in healthcare, where a hydrogel designed for a wound dressing must perform differently from one intended for drug delivery, tissue engineering, or a medical implant. A 2024 review published in Bioengineering & Translational Medicine documented more than 100 approved therapeutic hydrogel products and 210 active clinical trials involving injectable and non-injectable hydrogels, illustrating the breadth of clinical development across applications such as wound healing, ophthalmology, tissue regeneration, and drug delivery. Synthetic polymers contribute to this development because their molecular structures and processing methods can be modified to obtain specific functional characteristics. In wound care, hydrogel dressings can maintain a moist environment, while selected formulations can incorporate antimicrobial agents or other therapeutic compounds. In pharmaceutical delivery, polymer networks can hold drugs and regulate their release through swelling, degradation, or responses to changes in the surrounding environment. Beyond medical applications, synthetic superabsorbent hydrogels are widely used in personal care products, particularly disposable diapers and feminine hygiene products, where liquid absorption and retention are essential.
Drug delivery is gaining importance in the global hydrogel market because pharmaceutical development increasingly requires systems that can control where a medicine is released, how quickly it becomes available, and how long it remains active at the intended site. Hydrogels consist of water-loving polymer networks whose pore structure, crosslinking density, chemical composition, and degradation behaviour can be adjusted to influence the movement of an incorporated drug. This makes them suitable for exploring delivery approaches that go beyond conventional tablets, capsules, or immediate-release formulations. A review published in Nature Reviews Materials explains that hydrogels can provide spatial and temporal control over the release of small-molecule medicines, larger biological agents, and other therapeutic substances, while certain formulations can also protect sensitive compounds from degradation. Importantly, this application has moved beyond laboratory research into approved medical products. In the United States, the Food and Drug Administration approved Jelmyto in 2020 for adults with low-grade upper tract urothelial cancer. Its formulation uses a thermosensitive gel system containing mitomycin that is administered into the upper urinary tract, where it forms a gel to help deliver the medicine locally. The prescribing information also identifies important risks, including ureteric obstruction, demonstrating why clinical validation and patient monitoring remain essential.
Polyacrylate's global importance comes from the way its molecular structure converts a relatively small quantity of polymer into a network capable of absorbing and retaining substantial amounts of liquid. Cross-linked sodium polyacrylate contains hydrophilic carboxylate groups that attract water, while the interconnected polymer chains allow the material to swell without dissolving completely. This combination of absorption and structural stability has made polyacrylate based superabsorbent polymers particularly important in disposable baby diapers, feminine hygiene products, and adult incontinence products, where manufacturers need effective fluid retention without making products excessively bulky. A scientific review published in Progress in Polymer Science identifies cross-linked polyacrylate-based materials among the most commercially successful superabsorbent polymers, with established uses in hygiene and other absorbent products. Another significant application is advanced wound care. Superabsorbent wound dressings commonly incorporate sodium polyacrylate grains within an absorbent core, where the polymer helps capture wound exudate and retain fluid even when the dressing is subjected to pressure. This supports the management of wounds with moderate or high levels of exudate, although dressing selection must depend on clinical assessment and the specific product design. Polyacrylate chemistry also has relevance beyond personal care and medicine. In agriculture, acrylic-acid-based hydrogels can be incorporated into soil to absorb irrigation water and release some of it as surrounding conditions change.
Unlike hydrogel sheets, which are manufactured in a fixed form, amorphous hydrogels are supplied as viscous gels that can be applied directly to wounds with uneven surfaces, narrow cavities, or contours that are difficult to cover with conventional dressings. This flexibility makes them particularly relevant to wound care, where the dressing must suit the condition of the wound rather than simply fit a standard shape. Many amorphous formulations contain purified water, humectants such as glycerol, and hydrophilic polymers or modified starches that help retain moisture and maintain a spreadable consistency. By donating moisture to dry tissue, the gel can soften slough and necrotic material, supporting autolytic debridement, a process in which the body's own enzymes help break down devitalised tissue. Clinical wound-care guidance identifies amorphous gels as useful for selected pressure injuries and deeper wounds, especially where a dressing could shift because of movement or gravity. Their practical versatility also extends to burns, skin tears, and selected chronic wounds with low to moderate exudate, where maintaining a moist environment may support the healing process. A systematic review published in 2025 assessed 39 clinical studies involving hydrogel dressings and found evidence of potential benefits in chronic wound management, although it also highlighted the need for better long-term studies and evidence specific to individual wound types.
According to the research report "Global Hydrogel Market Outlook, 2031," published by Bonafide Research, the Global Hydrogel Market was valued at more than USD 21.75 Billion in 2025, and expected to reach a market size of more than USD 32.34 Billion by 2031 with the CAGR of 7.01% from 2026-2031. Smart hydrogels are engineered to respond to changes in temperature, pH, light, glucose concentration, enzymes, or other environmental signals. Unlike conventional gels, which mainly provide moisture or physical support, these materials can change their structure, swelling behaviour, or release characteristics when a specific trigger occurs. Temperature sensitive formulations can transition from a liquid to a gel near body temperature, while glucose responsive systems are being studied for more controlled insulin delivery. Polymer science is enabling hydrogels to become more durable, functional, and adaptable to specialised medical applications. Researchers are developing double-network structures, reversible cross links, conductive polymers, and hybrid systems that combine natural and synthetic ingredients. Reversible cross links can allow certain hydrogels to recover after deformation, while double-network designs can improve resistance to mechanical damage. Conductive hydrogels incorporate electrically active components, allowing researchers to investigate applications such as electrical stimulation, wearable bioelectronics, and wound monitoring. For example, a 2024 research study described a flexible photovoltaic powered hydrogel dressing that combined a light-powered electrical system, flexible electrodes and a conductive hydrogel interface to investigate electrical stimulation for infected diabetic wounds.
Synthetic hydrogels hold a strong position globally because manufacturers can engineer their properties to suit different products and performance requirements rather than depending entirely on the characteristics of naturally sourced materials. Polymers such as polyvinyl alcohol (PVA), polyethylene glycol (PEG), and polyacrylate-based materials can be formulated with different crosslinking structures to control water absorption, elasticity, porosity, degradation, and the release of incorporated substances. This adaptability is especially important in healthcare, where a hydrogel designed for a wound dressing must perform differently from one intended for drug delivery, tissue engineering, or a medical implant. A 2024 review published in Bioengineering & Translational Medicine documented more than 100 approved therapeutic hydrogel products and 210 active clinical trials involving injectable and non-injectable hydrogels, illustrating the breadth of clinical development across applications such as wound healing, ophthalmology, tissue regeneration, and drug delivery. Synthetic polymers contribute to this development because their molecular structures and processing methods can be modified to obtain specific functional characteristics. In wound care, hydrogel dressings can maintain a moist environment, while selected formulations can incorporate antimicrobial agents or other therapeutic compounds. In pharmaceutical delivery, polymer networks can hold drugs and regulate their release through swelling, degradation, or responses to changes in the surrounding environment. Beyond medical applications, synthetic superabsorbent hydrogels are widely used in personal care products, particularly disposable diapers and feminine hygiene products, where liquid absorption and retention are essential.
Drug delivery is gaining importance in the global hydrogel market because pharmaceutical development increasingly requires systems that can control where a medicine is released, how quickly it becomes available, and how long it remains active at the intended site. Hydrogels consist of water-loving polymer networks whose pore structure, crosslinking density, chemical composition, and degradation behaviour can be adjusted to influence the movement of an incorporated drug. This makes them suitable for exploring delivery approaches that go beyond conventional tablets, capsules, or immediate-release formulations. A review published in Nature Reviews Materials explains that hydrogels can provide spatial and temporal control over the release of small-molecule medicines, larger biological agents, and other therapeutic substances, while certain formulations can also protect sensitive compounds from degradation. Importantly, this application has moved beyond laboratory research into approved medical products. In the United States, the Food and Drug Administration approved Jelmyto in 2020 for adults with low-grade upper tract urothelial cancer. Its formulation uses a thermosensitive gel system containing mitomycin that is administered into the upper urinary tract, where it forms a gel to help deliver the medicine locally. The prescribing information also identifies important risks, including ureteric obstruction, demonstrating why clinical validation and patient monitoring remain essential.
Polyacrylate's global importance comes from the way its molecular structure converts a relatively small quantity of polymer into a network capable of absorbing and retaining substantial amounts of liquid. Cross-linked sodium polyacrylate contains hydrophilic carboxylate groups that attract water, while the interconnected polymer chains allow the material to swell without dissolving completely. This combination of absorption and structural stability has made polyacrylate based superabsorbent polymers particularly important in disposable baby diapers, feminine hygiene products, and adult incontinence products, where manufacturers need effective fluid retention without making products excessively bulky. A scientific review published in Progress in Polymer Science identifies cross-linked polyacrylate-based materials among the most commercially successful superabsorbent polymers, with established uses in hygiene and other absorbent products. Another significant application is advanced wound care. Superabsorbent wound dressings commonly incorporate sodium polyacrylate grains within an absorbent core, where the polymer helps capture wound exudate and retain fluid even when the dressing is subjected to pressure. This supports the management of wounds with moderate or high levels of exudate, although dressing selection must depend on clinical assessment and the specific product design. Polyacrylate chemistry also has relevance beyond personal care and medicine. In agriculture, acrylic-acid-based hydrogels can be incorporated into soil to absorb irrigation water and release some of it as surrounding conditions change.
Unlike hydrogel sheets, which are manufactured in a fixed form, amorphous hydrogels are supplied as viscous gels that can be applied directly to wounds with uneven surfaces, narrow cavities, or contours that are difficult to cover with conventional dressings. This flexibility makes them particularly relevant to wound care, where the dressing must suit the condition of the wound rather than simply fit a standard shape. Many amorphous formulations contain purified water, humectants such as glycerol, and hydrophilic polymers or modified starches that help retain moisture and maintain a spreadable consistency. By donating moisture to dry tissue, the gel can soften slough and necrotic material, supporting autolytic debridement, a process in which the body's own enzymes help break down devitalised tissue. Clinical wound-care guidance identifies amorphous gels as useful for selected pressure injuries and deeper wounds, especially where a dressing could shift because of movement or gravity. Their practical versatility also extends to burns, skin tears, and selected chronic wounds with low to moderate exudate, where maintaining a moist environment may support the healing process. A systematic review published in 2025 assessed 39 clinical studies involving hydrogel dressings and found evidence of potential benefits in chronic wound management, although it also highlighted the need for better long-term studies and evidence specific to individual wound types.
Related Press Releases
Quick Contacts
Trusted Partners
Latest Press Release
We are friendly and approachable, give us a call.